Fintel on MSN1d
Canaccord Genuity Upgrades Viant Technology (DSP)
Fintel reports that on November 13, 2024, Canaccord Genuity upgraded their outlook for Viant Technology (NasdaqGS:DSP) from ...
Hosted on MSN1d
Canaccord Genuity Downgrades Doximity (DOCS)
Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to ...
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...
Canaccord Genuity Sticks to Its Buy Rating for PYC Therapeutics Limited (PYC)
In a report released on November 11, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on PYC Therapeutics Limited (PYC – ...
bovnews1d
Canaccord Genuity Issues Buy Rating for Blend Labs Inc (BLND) Stock
On Wednesday, Blend Labs Inc (BLND) stock saw a decline, ending the day at $4.36 which represents a decrease of $-0.19 or -4.18% from the prior close of $4.55. The stock opened at $4.59 and touched a ...